Skip to the content
Please enable JavaScript in your browser to complete this form.
Evaluation Form
Location
*
[Please Select]
Hong Kong
Macau
Others
Please Specify
Title
*
First Name :
*
Last Name :
*
Institute
*
Email Address
*
Email
Confirm Email
MCHK Registration Number
CME Accreditation
*
[Please Select]
Hong Kong College of Physicians
The Hong Kong College of Family Physicians
The Hong Kong College of Pathologists
Medical Council of Hong Kong
Not applicable
1. How useful was Dr Furie's lecture in increasing your understanding on the unmet needs of SLE patients?
*
4 (Very Useful)
3
2
1
0 (Not at all)
2. Was the presentation helpful in increasing your understanding on the clinical use of Anifrolumab in SLE patients?
*
4 (Very Helpful)
3
2
1
0 (Not at all)
3. Do you think Type 1 interferon plays an important role in driving SLE pathophysiology?
*
4 (Very Important)
3
2
1
0 (Not at all)
4. Do you agree SLE patient with OCS dose >7.5 mg/day is in need of treatment change?
*
4 (Strongly Agree)
3 (Agree)
2 (Neutral)
1 (Disagree)
0 (Strongly Disagree)
5. What other topics are you interested to learn more about?
TULIP study data and endpoint discordance
Clinical burden and unmet needs of current SLE treatments e.g., glucocorticoids and immunosuppressants
Clinical relevance of upstream interferon signaling and SLE pathophysiology
Physician experience sharing on Anifrolumab use in SLE patients
Others:
Please Specify :
Submit